TECHNOLOGY & DATA MANAGEMENT T


he Covid-19 pandemic pushed the healthcare industry towards rapid digitalisation, with the rise of telehealth,


telepresence systems, remote diagnostics, predictive AI, and wearable technology now changing the way healthcare is delivered and improving patient outcomes.


Emerging technologies such as AR and VR are becoming increasingly routine for professional training, surgical assistance, and treatment for psychological and neurological disorders. For pharma and medical devices, AR, VR and AI are rapidly accelerating drug discovery, manfactring and spply chain efficiencies. However, commercial uptake and affordability to these technologies remain limiting factors to the widespread adoption of new digital products and opportunities.


The metaverse remains too risky for healthcare Although metaverse technologies show promise to reinvent healthcare approaches and bring new experiences to healthcare providers and patients in the coming years, adoption is still at an early stage. For example, the metaverse could improve


access to care for all patients, regardless of their location. The use of telemedicine surged in popularity during Covid-19, when practitioners fond they cold efficiently and quickly diagnose many conditions without needing to physically examine patients. While not at the same level at the start of the pandemic, demand for digital solutions to access healthcare services has remained high since. Telemedicine consultations through VR


would allow patients to access the best specialists anywhere, not limited by physical location. Holoportation could potentially allow doctors and patients to share the same virtual space, and even allow doctors to examine a patient through a 3D projection. Patients living in remote regions could be


seen by healthcare professionals without having to travel great distances, and access to care for disabled or elderly people could improve significantly. Virtual pharmacies could allow patients to pick up prescriptions directly from the


“The use of telemedicine surged in popularity during Covid-19, when practitioners found they could eciently and quickly diagnose many conditions without needing to physically examine patients”


metaverse and have their drugs delivered to their homes. For example, US pharmacy chain  has filed to trademar its pharmacy, virtal goods and health services in the metaverse.


Metaverse depends on access to technology Remote access to healthcare services in the metaverse would be dependent on access to the necessary equipment, however. As the metaverse promises to improve access to care for all patients, a lack of access to or the unaffordability of technology will further contribute to the current inequality in access to healthcare. Not all patients will have a positive attitude


towards receiving treatment online or remotely. lder poplations may find it more difficlt to adapt and embrace modern technologies. The use of telemedicine and building virtual hospitals bring issues surrounding patient confidentiality. nhanced secrity systems will be needed to ensure patient data is accessible only to specific hospital staff. The metaverse industry needs to overcome major challenges for healthcare before widespread adoption occurs. Evidence of proven use cases and participation by a critical mass of users is imperative to convince a shift in metaverse investment. The metaverse will require investment and support from healthcare companies if it is to significantly change the landscape of the industry.


Outsourcing In Clinical Trials | 37


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72